Beacon Checkpoint Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Checkpoint drug, trial and commercial data.
- Access to 2,000+ Drugs, 14,000+ Trials, 2,000+ Companies, and 2,000+ Deals in the Checkpoint space
- Market leading ontologies, enabling precise navigation of specific Checkpoint therapeutics
- Manually curated by Checkpoint scientists, with data updated daily
- Your one stop shop for Checkpoint intelligence data
Why Beacon Checkpoint Database?
Advanced Search Filtering
Drill down into Beacon’s Checkpoint drug and trial data with a unique selection of >30 search filters. Segment the Checkpoint drug and trial landscape to identify the data that matters most to you. Our filters include:
Drug Target
Drug Modality
Disease Indication
Drug Status
Drug & Trial Milestones
Trial Phase & Location
How Beacon Checkpoint Database Can Help You?
Leverage Beacon’s proprietary clinical trial searching filters to run highly targeted combination searches across 10,000+ checkpoint combination trials leveraging checkpoint modulators in combination with other modalities
Take advantage of our comprehensive modality tagging within checkpoint drugs & other datasets such as ADCs, Bispecifics, Cancer Vaccines & RNA drugs to laser in on successful strategies & access curated clinical design data points.
Benchmark your preclinical checkpoint research with confidence by accessing more preclinical data than anywhere else, spread across curated in vitro, efficacy, toxicity & PK data released for every checkpoint program in one place, allowing you to compare every readout against the wider field and understand your opportunity when competing against blockbuster drugs on the market
Track all checkpoint clinical developments for a given target through to approvals with a market leading curation approach, segmenting clinical readouts into drug dosing, patient data, toxicity & results, with rapid visibility into high performing drugs including overall & partial response, progression free survival & other vital readouts
Optimize your checkpoint partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s unique approach to capturing early-stage companies and curated insights on deals & pipelines all in one place
Bulletproof your checkpoint investment strategy by confidently communicating your position in the market to investors & potential partners, with well benchmarked science, allowing you to stand out in a competitive market using robust data from Beacon.
Beacon helps developers stand out by providing comprehensive insights into targets, diseases & combination strategies & enhances your ability to attract investors and secure the capital needed to take your checkpoint drug to the next phase.
Beacon Checkpoint Database: The Numbers
Beacon Checkpoint Database: Key Data Segments
Drug Data
Revolutionize your landscape searching for Checkpoint-based therapies
Utilize >20 search filters to find programs based on disease indication, drug modality, drug target, and many more.
Trial Data
Optimize your Checkpoint clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Checkpoint trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication and more.
Milestones
A unique Checkpoint-based therapy development milestone filter and visualization tool.
Track past, present, and future Checkpoint drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Checkpoint-based therapy company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Checkpoint-based therapy partnership & fundraising projects
Search Checkpoint-based therapy deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more
Beacon Checkpoint Database: Drug Modalities
Analyze 2,000+ drugs (preclinical and clinical) and 14,000+ clinical trials (from early to late stage).
Beacon Checkpoint cover drugs that act to overcome natural, or tumor-created tolerance, including 41 specific targets:
- Co-inhibitory targets: PD-1 PD-L1 CTLA-4 TIM-3 TIGIT B7-H3 LAG-3 ADORA SIRP-alpha VISTA B7-H4 PD-L2 ILT-2 ILT-3 ILT-4 ILT-5 PVRIG CD96 LAIR 1
- Co-stimulatory targets: OX-40 OX-40L GITR 4-1BB 4-1BBL CD27 ICOS CD47 CD40 CD40L CD70 CD80 TLR7 TLR8 TLR9 LAIR 2
- Innate immunity / Tumor microenvironment targets: IDO NKG2A KIR STING CD73 CD39
Beacon Checkpoint also includes a host of preclinical data including, cell line and animal model experimental data.
Who Is Beacon Checkpoint Database For?
Beacon Checkpoint is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the Checkpoint drug development landscape.
Scientific Strategy Leader
Select the right pipeline for your Checkpoint drug development
Research Scientist
Validate new targets & inform your Checkpoint drug design
Clinical Development
Design optimized Checkpoint clinical trials & benchmark against the competition
Business Development
Uncover new Checkpoint therapy licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Checkpoint technologies
Translational Development
Confidently take your preclinical Checkpoint therapy into the clinic
Related Solutions
Check out additional solutions available from Beacon
Additional Resources
Check out Checkpoint related resources available from Beacon
Our Experts
Zer En Peng
Lead Research Analyst
Jake Morris
Account Manager
Eleni Taoula
